{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:01:34Z","timestamp":1791846094783,"version":"4.3.4"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41579-026-01331-w","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:38:32Z","timestamp":1782117512000},"page":"732-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Klebsiella genus as driver of human disease: from infections to non-communicable disorders"],"prefix":"10.1038","volume":"24","author":[{"given":"Serena","family":"Porcari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8909-0107","authenticated-orcid":false,"given":"Margherita","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Melekhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Sveva","family":"Carl\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"De Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-2110","authenticated-orcid":false,"given":"Eran","family":"Elinav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ianiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","volume":"31","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2018","unstructured":"Rodr\u00edguez-Ba\u00f1o, J., Guti\u00e9rrez-Guti\u00e9rrez, B., Machuca, I. & Pascual, A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Rev. 31, e00079-17 (2018).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-022-05620-1","volume":"614","author":"M Valles-Colomer","year":"2023","unstructured":"Valles-Colomer, M. et al. The person-to-person transmission landscape of the gut and oral microbiomes. Nature 614, 125\u2013135 (2023). This paper describes human microbiota transmission and lays groundwork for the pathogenic role of pathobionts in non-communicable disorders.","journal-title":"Nature"},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41579-025-01166-x","volume":"23","author":"V Heidrich","year":"2025","unstructured":"Heidrich, V., Valles-Colomer, M. & Segata, N. Human microbiome acquisition and transmission. Nat. Rev. Microbiol. 23, 568\u2013584 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","volume":"604","author":"R Gacesa","year":"2022","unstructured":"Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732\u2013739 (2022).","journal-title":"Nature"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392\u2013400 (2018).","journal-title":"Nat. Med."},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69\u201375 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1331_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.932","volume":"4","author":"DA Pariseau","year":"2024","unstructured":"Pariseau, D. A., Ring, B. E., Khadka, S. & Mike, L. A. Cultivation and genomic DNA extraction of Klebsiella pneumoniae. Curr. Protoc. 4, e932 (2024).","journal-title":"Curr. Protoc."},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/infdis\/jiu157","volume":"210","author":"E Diago-Navarro","year":"2014","unstructured":"Diago-Navarro, E. et al. Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule-associated virulence traits. J. Infect. Dis. 210, 803\u2013813 (2014).","journal-title":"J. Infect. Dis."},{"key":"1331_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.20411\/pai.v10i1.777","volume":"10","author":"D Al Ismail","year":"2025","unstructured":"Al Ismail, D., Campos-Madueno, E. I., Don\u00e0, V. & Endimiani, A. Hypervirulent Klebsiella pneumoniae (hvKp): overview, epidemiology and laboratory detection. Pathog. Immun. 10, 80\u2013119 (2025).","journal-title":"Pathog. Immun."},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/bacteria2040012","volume":"2","author":"R Khan","year":"2023","unstructured":"Khan, R., Wali, S. & Pari, B. Comprehensive analysis of Klebsiella pneumoniae culture identification and antibiogram: implications for antimicrobial susceptibility patterns from sputum samples in Mardan, Khyber Pakhtunkhwa, Pakistan. Bacteria 2, 155\u2013173 (2023).","journal-title":"Bacteria"},{"key":"1331_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1068888","volume":"10","author":"HN Altayb","year":"2022","unstructured":"Altayb, H. N. et al. Molecular insights into novel environmental strains of Klebsiella quasipneumoniae harboring different antimicrobial-resistance genes. Front. Public Health 10, 1068888 (2022).","journal-title":"Front. Public Health"},{"key":"1331_CR12","doi-asserted-by":"publisher","first-page":"e00006","DOI":"10.1128\/CMR.00006-21","volume":"35","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Klebsiella oxytoca complex: update on taxonomy, antimicrobial resistance, and virulence. Clin. Microbiol. Rev. 35, e00006\u2013e00021 (2022).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"W78","DOI":"10.1093\/nar\/gkae268","volume":"52","author":"I Letunic","year":"2024","unstructured":"Letunic, I. & Bork, P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 52, W78\u2013W82 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1331_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108875","volume":"27","author":"T-H Teo","year":"2024","unstructured":"Teo, T.-H. et al. Differential mucosal tropism and dissemination of classical and hypervirulent Klebsiella pneumoniae infection. iScience 27, 108875 (2024).","journal-title":"iScience"},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"7107","DOI":"10.1128\/IAI.72.12.7107-7114.2004","volume":"72","author":"MA Campos","year":"2004","unstructured":"Campos, M. A. et al. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72, 7107\u20137114 (2004).","journal-title":"Infect. Immun."},{"key":"1331_CR16","doi-asserted-by":"publisher","first-page":"1450984","DOI":"10.3389\/fmicb.2025.1450984","volume":"16","author":"L Zierke","year":"2025","unstructured":"Zierke, L., Mourad, R., Kohler, T. P., M\u00fcsken, M. & Hammerschmidt, S. Influence of the polysaccharide capsule on virulence and fitness of Klebsiella pneumoniae. Front. Microbiol. 16, 1450984 (2025).","journal-title":"Front. Microbiol."},{"key":"1331_CR17","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1099\/mic.0.050336-0","volume":"157","author":"C-R Hsu","year":"2011","unstructured":"Hsu, C.-R., Lin, T.-L., Chen, Y.-C., Chou, H.-C. & Wang, J.-T. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology 157, 3446\u20133457 (2011).","journal-title":"Microbiology"},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"11562","DOI":"10.3390\/ijms222111562","volume":"22","author":"M Kaszowska","year":"2021","unstructured":"Kaszowska, M. et al. The mutation in wbaP cps gene cluster selected by phage-borne depolymerase abolishes capsule production and diminishes the virulence of Klebsiella pneumoniae. Int. J. Mol. Sci. 22, 11562 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1331_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep15573","volume":"5","author":"Y-J Pan","year":"2015","unstructured":"Pan, Y.-J. et al. Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp. Sci. Rep. 5, 15573 (2015).","journal-title":"Sci. Rep."},{"key":"1331_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00359-23","volume":"11","author":"C-C Tsai","year":"2023","unstructured":"Tsai, C.-C. et al. A 20-year study of capsular polysaccharide seroepidemiology, susceptibility profiles, and virulence determinants of Klebsiella pneumoniae from bacteremia patients in Taiwan. Microbiol. Spectr. 11, e0035923 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1099\/mic.0.000827","volume":"165","author":"S Pal","year":"2019","unstructured":"Pal, S. et al. Absence of the glycosyltransferase WcaJ in Klebsiella pneumoniae ATCC13883 affects biofilm formation, increases polymyxin resistance and reduces murine macrophage activation. Microbiology 165, 891\u2013904 (2019).","journal-title":"Microbiology"},{"key":"1331_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03838-24","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu, X. et al. Capsular polysaccharide enables Klebsiella pneumoniae to evade phagocytosis by blocking host-bacteria interactions. mBio 16, e0383824 (2025).","journal-title":"mBio"},{"key":"1331_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010693","volume":"18","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Capsule type defines the capability of Klebsiella pneumoniae in evading Kupffer cell capture in the liver. PLoS Pathog. 18, e1010693 (2022).","journal-title":"PLoS Pathog."},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"105014","DOI":"10.1016\/j.micpath.2021.105014","volume":"158","author":"P Lan","year":"2021","unstructured":"Lan, P. et al. Genetic diversity of siderophores and hypermucoviscosity phenotype in Klebsiella pneumoniae. Microb. Pathog. 158, 105014 (2021).","journal-title":"Microb. Pathog."},{"key":"1331_CR25","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1128\/IAI.00430-15","volume":"83","author":"TA Russo","year":"2015","unstructured":"Russo, T. A., Olson, R., MacDonald, U., Beanan, J. & Davidson, B. A. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth\/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect. Immun. 83, 3325\u20133333 (2015).","journal-title":"Infect. Immun."},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"e00224","DOI":"10.1128\/mBio.00224-11","volume":"3","author":"MA Bachman","year":"2012","unstructured":"Bachman, M. A., Lenio, S., Schmidt, L., Oyler, J. E. & Weiser, J. N. Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio 3, e00224-11 (2012).","journal-title":"mBio"},{"key":"1331_CR27","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1128\/IAI.05114-11","volume":"79","author":"MA Bachman","year":"2011","unstructured":"Bachman, M. A. et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79, 3309\u20133316 (2011).","journal-title":"Infect. Immun."},{"key":"1331_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1471-2180-10-179","volume":"10","author":"C Schroll","year":"2010","unstructured":"Schroll, C., Barken, K. B., Krogfelt, K. A. & Struve, C. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol. 10, 179 (2010).","journal-title":"BMC Microbiol."},{"key":"1331_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409655121","volume":"121","author":"EDB Lopatto","year":"2024","unstructured":"Lopatto, E. D. B. et al. Conformational ensembles in Klebsiella pneumoniae FimH impact uropathogenesis. Proc. Natl Acad. Sci. USA 121, e2409655121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1331_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03076-24","volume":"13","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Regulation of type 3 fimbria expression by RstA affects biofilm formation and virulence in Klebsiella pneumoniae ATCC43816. Microbiol. Spectr. 13, e0307624 (2025).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jmii.2024.10.002","volume":"58","author":"T-H Lin","year":"2025","unstructured":"Lin, T.-H., Wang, C.-Y., Wu, C.-C. & Lin, C.-T. Impacts of Pta-AckA pathway on CPS biosynthesis and type 3 fimbriae expression in Klebsiella pneumoniae. J. Microbiol. Immunol. Infect. 58, 48\u201355 (2025).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"1331_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fcimb.2017.00103","volume":"7","author":"M-C Lu","year":"2017","unstructured":"Lu, M.-C. et al. Colibactin contributes to the hypervirulence of pks+ K1 CC23 Klebsiella pneumoniae in mouse meningitis infections. Front. Cell. Infect. Microbiol. 7, 103 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1331_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.toxicon.2021.04.007","volume":"197","author":"N Strakova","year":"2021","unstructured":"Strakova, N., Korena, K. & Karpiskova, R. Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development\u00a0\u2014 a systematic review. Toxicon 197, 126\u2013135 (2021).","journal-title":"Toxicon"},{"key":"1331_CR34","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.052709699","volume":"99","author":"C Hetz","year":"2002","unstructured":"Hetz, C., Bono, M. R., Barros, L. F. & Lagos, R. Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc. Natl Acad. Sci. USA 99, 2696\u20132701 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1331_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71487-z","volume":"14","author":"FM Masson","year":"2024","unstructured":"Masson, F. M. et al. Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization. Sci. Rep. 14, 20701 (2024).","journal-title":"Sci. Rep."},{"key":"1331_CR36","doi-asserted-by":"publisher","first-page":"18562","DOI":"10.1074\/jbc.M500490200","volume":"280","author":"R Hari-Dass","year":"2005","unstructured":"Hari-Dass, R. et al. Serum amyloid a protein binds to outer membrane protein a of Gram-negative bacteria. J. Biol. Chem. 280, 18562\u201318567 (2005).","journal-title":"J. Biol. Chem."},{"key":"1331_CR37","doi-asserted-by":"publisher","first-page":"128262","DOI":"10.1016\/j.micres.2025.128262","volume":"299","author":"W Zeng","year":"2025","unstructured":"Zeng, W. et al. Outer membrane protein A mediates Klebsiella pneumoniae penetration of the blood-brain barrier and induces bacterial meningitis. Microbiol. Res. 299, 128262 (2025).","journal-title":"Microbiol. Res."},{"key":"1331_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1128\/AAC.00657-08","volume":"53","author":"E Llobet","year":"2009","unstructured":"Llobet, E., March, C., Gim\u00e9nez, P. & Bengoechea, J. A. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob. Agents Chemother. 53, 298\u2013302 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03807-23","volume":"12","author":"V Tiwari","year":"2024","unstructured":"Tiwari, V. et al. Klebsiella pneumoniae DedA family proteins have redundant roles in divalent cation homeostasis and resistance to phagocytosis. Microbiol. Spectr. 12, e0380723 (2024).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR40","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.1128\/MMBR.00135-20","volume":"85","author":"RK Fritts","year":"2021","unstructured":"Fritts, R. K., McCully, A. L. & McKinlay, J. B. Extracellular metabolism sets the table for microbial cross-feeding. Microbiol. Mol. Biol. Rev. 85, e00135\u201320 (2021).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1331_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36252-2","volume":"14","author":"L Semenec","year":"2023","unstructured":"Semenec, L. et al. Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence. Nat. Commun. 14, 702 (2023).","journal-title":"Nat. Commun."},{"key":"1331_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1979883","volume":"13","author":"N-N Li","year":"2021","unstructured":"Li, N.-N. et al. High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo. Gut Microbes 13, 1979883 (2021). This paper demonstrates the connection between nonalcoholic steatohepatitis and endogenous production of alcohol by K. pneumoniae strains.","journal-title":"Gut Microbes"},{"key":"1331_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104560","volume":"91","author":"G Xue","year":"2023","unstructured":"Xue, G. et al. Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study. EBioMedicine 91, 104560 (2023).","journal-title":"EBioMedicine"},{"key":"1331_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00052-24","volume":"9","author":"M Shen","year":"2024","unstructured":"Shen, M. et al. Alcohol-induced gut microbiome dysbiosis enhances the colonization of Klebsiella pneumoniae on the mouse intestinal tract. mSystems 9, e00052-24 (2024).","journal-title":"mSystems"},{"key":"1331_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"PA Bradford","year":"2001","unstructured":"Bradford, P. A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933\u2013951 (2001).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR46","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1086\/344654","volume":"36","author":"DM Livermore","year":"2003","unstructured":"Livermore, D. M. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36, S11\u2013S23 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout, J. D. & Laupland, K. B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8, 159\u2013166 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"1331_CR48","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JDD Pitout","year":"2015","unstructured":"Pitout, J. D. D., Nordmann, P. & Poirel, L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob. Agents Chemother. 59, 5873\u20135884 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR49","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"LS Tzouvelekis","year":"2012","unstructured":"Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T. & Daikos, G. L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25, 682\u2013707 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-17044-8","volume":"15","author":"S Hanna","year":"2025","unstructured":"Hanna, S. et al. Exploring mutational possibilities of KPC variants to reach high-level resistance to cefiderocol. Sci. Rep. 15, 31312 (2025).","journal-title":"Sci. Rep."},{"key":"1331_CR51","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/14756366.2017.1344235","volume":"32","author":"T Naas","year":"2017","unstructured":"Naas, T. et al. Beta-lactamase database (BLDB): structure and function. J. Enzyme Inhib. Med. Chem. 32, 917\u2013919 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"1331_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1128\/AAC.00693-09","volume":"54","author":"KM Papp-Wallace","year":"2010","unstructured":"Papp-Wallace, K. M. et al. Inhibitor resistance in the KPC-2 \u03b2-lactamase, a preeminent property of this class A \u03b2-lactamase. Antimicrob. Agents Chemother. 54, 890\u2013897 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR53","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann, P., Naas, T. & Poirel, L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17, 1791\u20131798 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"1331_CR54","doi-asserted-by":"publisher","first-page":"e00102","DOI":"10.1128\/CMR.00102-19","volume":"33","author":"JDD Pitout","year":"2019","unstructured":"Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K. A. & Matsumura, Y. The global ascendency of OXA-48-type carbapenemases. Clin. Microbiol. Rev. 33, e00102\u2013e00119 (2019).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","volume":"48","author":"L Poirel","year":"2004","unstructured":"Poirel, L., H\u00e9ritier, C., Tol\u00fcn, V. & Nordmann, P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48, 15\u201322 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR56","doi-asserted-by":"publisher","first-page":"e01195","DOI":"10.1128\/AAC.01195-18","volume":"62","author":"A Stewart","year":"2018","unstructured":"Stewart, A., Harris, P., Henderson, A. & Paterson, D. Treatment of infections by OXA-48-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 62, e01195-18 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00148-25","volume":"207","author":"Y Su","year":"2025","unstructured":"Su, Y. et al. Molecular characterization and resistance mechanisms of ertapenem-non-susceptible carbapenem-resistant Klebsiella pneumoniae co-harboring ESBLs or AmpC enzymes with porin loss or efflux pump overexpression. J. Bacteriol. 207, e00148-25 (2025).","journal-title":"J. Bacteriol."},{"key":"1331_CR58","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1128\/CMR.11.4.589","volume":"11","author":"R Podschun","year":"1998","unstructured":"Podschun, R. & Ullmann, U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11, 589\u2013603 (1998).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR59","doi-asserted-by":"publisher","first-page":"4.1.06","DOI":"10.1128\/microbiolspec.UTI-0005-2012","volume":"4","author":"S Clegg","year":"2016","unstructured":"Clegg, S. & Murphy, C. N. Epidemiology and virulence of Klebsiella pneumoniae. Microbiol. Spectr. 4, 4.1.06 (2016).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/ciad507","volume":"78","author":"DJ Roach","year":"2024","unstructured":"Roach, D. J. et al. Clinical and genomic characterization of a cohort of patients with Klebsiella pneumoniae bloodstream infection. Clin. Infect. Dis. 78, 31\u201339 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107275","volume":"64","author":"X Han","year":"2024","unstructured":"Han, X. et al. Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae. Int. J. Antimicrob. Agents 64, 107275 (2024).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1331_CR62","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/jac\/dkae227","volume":"79","author":"Q Shi","year":"2024","unstructured":"Shi, Q. et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study. J. Antimicrob. Chemother. 79, 2292\u20132297 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"1331_CR63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1473-3099(17)30489-9","volume":"18","author":"D Gu","year":"2018","unstructured":"Gu, D. et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect. Dis. 18, 37\u201346 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1331_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1473-3099(22)00009-3","volume":"22","author":"C Liu","year":"2022","unstructured":"Liu, C., Dong, N., Chan, E. W. C., Chen, S. & Zhang, R. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in China, 2016-20. Lancet Infect. Dis. 22, 167\u2013168 (2022). This paper provides an update of carbapenem resistance in China.","journal-title":"Lancet Infect. Dis."},{"key":"1331_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46998-9","volume":"9","author":"H Barrios-Camacho","year":"2019","unstructured":"Barrios-Camacho, H. et al. Molecular epidemiology of Klebsiella variicola obtained from different sources. Sci. Rep. 9, 10610 (2019).","journal-title":"Sci. Rep."},{"key":"1331_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004982","volume":"4","author":"S Brisse","year":"2009","unstructured":"Brisse, S. et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS ONE 4, e4982 (2009).","journal-title":"PLoS ONE"},{"key":"1331_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00630-15","volume":"6","author":"C Struve","year":"2015","unstructured":"Struve, C. et al. Mapping the evolution of hypervirulent Klebsiella pneumoniae. mBio 6, e00630 (2015).","journal-title":"mBio"},{"key":"1331_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01332-5","volume":"16","author":"S Hala","year":"2024","unstructured":"Hala, S. et al. The emergence of highly resistant and hypervirulent Klebsiella pneumoniae CC14 clone in a tertiary hospital over 8 years. Genome Med. 16, 58 (2024).","journal-title":"Genome Med."},{"key":"1331_CR69","unstructured":"World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Antibiotic Use Data for 2022 (WHO, 2025)."},{"key":"1331_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-022-02110-3","volume":"11","author":"T Tesfa","year":"2022","unstructured":"Tesfa, T., Mitiku, H., Edae, M. & Assefa, N. Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis. Syst. Rev. 11, 240 (2022).","journal-title":"Syst. Rev."},{"key":"1331_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","volume":"12","author":"T Karampatakis","year":"2023","unstructured":"Karampatakis, T., Tsergouli, K. & Behzadi, P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics 12, 234 (2023).","journal-title":"Antibiotics"},{"key":"1331_CR72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcimb.2018.00004","volume":"8","author":"RM Martin","year":"2018","unstructured":"Martin, R. M. & Bachman, M. A. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front. Cell. Infect. Microbiol. 8, 4 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1331_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect. Dis. 19, 56\u201366 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1331_CR74","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"1331_CR75","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.clinthera.2015.03.009","volume":"37","author":"YW Min","year":"2015","unstructured":"Min, Y. W. & Rhee, P.-L. The role of microbiota on the gut immunology. Clin. Ther. 37, 968\u2013975 (2015).","journal-title":"Clin. Ther."},{"key":"1331_CR76","doi-asserted-by":"publisher","first-page":"2205272","DOI":"10.1002\/advs.202205272","volume":"10","author":"J Gong","year":"2023","unstructured":"Gong, J. et al. Mesenteric adipose tissue-derived Klebsiella variicola disrupts intestinal barrier and promotes colitis by type VI secretion system. Adv. Sci. 10, 2205272 (2023).","journal-title":"Adv. Sci."},{"key":"1331_CR77","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185, 2879\u20132898.e24 (2022). This paper shows how a combination of bacteriophages can be used to specifically target K. pneumoniae strains in the context of IBD.","journal-title":"Cell"},{"key":"1331_CR78","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15, 382\u2013392 (2014).","journal-title":"Cell Host Microbe"},{"key":"1331_CR79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12941-023-00630-x","volume":"22","author":"AA Kharaghani","year":"2023","unstructured":"Kharaghani, A. A. et al. High prevalence of mucosa-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD). Ann. Clin. Microbiol. Antimicrob. 22, 86 (2023).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"1331_CR80","doi-asserted-by":"publisher","first-page":"1015890","DOI":"10.3389\/fcimb.2022.1015890","volume":"12","author":"B Khorsand","year":"2022","unstructured":"Khorsand, B. et al. Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn\u2019s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Front. Cell. Infect. Microbiol. 12, 1015890 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1331_CR81","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/ibd\/izac175","volume":"29","author":"J Hellmann","year":"2023","unstructured":"Hellmann, J. et al. Patient-reported outcomes correlate with microbial community composition independent of mucosal inflammation in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 29, 286\u2013296 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"1331_CR82","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/ecco-jcc\/jjac155","volume":"17","author":"K Elmaghrawy","year":"2023","unstructured":"Elmaghrawy, K. et al. The oral microbiome in treatment-na\u00efve paediatric IBD patients exhibits dysbiosis related to disease severity that resolves following therapy. J. Crohns Colitis 17, 553\u2013564 (2023).","journal-title":"J. Crohns Colitis"},{"key":"1331_CR83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.aan4526","volume":"358","author":"K Atarashi","year":"2017","unstructured":"Atarashi, K. et al. Ectopic colonization of oral bacteria in the intestine drives TH 1 cell induction and inflammation. Science 358, 359\u2013365 (2017). This paper shows that Klebsiella spp. can trigger chronic inflammation in the gut.","journal-title":"Science"},{"key":"1331_CR84","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2333463","volume":"16","author":"Y Guo","year":"2024","unstructured":"Guo, Y. et al. Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa. Gut Microbes 16, 2333463 (2024).","journal-title":"Gut Microbes"},{"key":"1331_CR85","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.chom.2010.08.004","volume":"8","author":"WS Garrett","year":"2010","unstructured":"Garrett, W. S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292\u2013300 (2010).","journal-title":"Cell Host Microbe"},{"key":"1331_CR86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492\u2013503 (2019).","journal-title":"Nat. Microbiol."},{"key":"1331_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2020.05.048","volume":"182","author":"S Kitamoto","year":"2020","unstructured":"Kitamoto, S. et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell 182, 447\u2013462.e14 (2020).","journal-title":"Cell"},{"key":"1331_CR88","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/MEG.0b013e328318ecde","volume":"21","author":"T Rashid","year":"2009","unstructured":"Rashid, T., Ebringer, A., Tiwana, H. & Fielder, M. Role of Klebsiella and collagens in Crohn\u02bcs disease: a new prospect in the use of low-starch diet. Eur. J. Gastroenterol. Hepatol. 21, 843\u2013849 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"1331_CR89","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10067-006-0391-2","volume":"26","author":"A Ebringer","year":"2007","unstructured":"Ebringer, A., Rashid, T., Tiwana, H. & Wilson, C. A possible link between Crohn\u2019s disease and ankylosing spondylitis via Klebsiella infections. Clin. Rheumatol. 26, 289\u2013297 (2007).","journal-title":"Clin. Rheumatol."},{"key":"1331_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/rheumatology\/40.1.15","volume":"40","author":"H Tiwana","year":"2001","unstructured":"Tiwana, H. et al. Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn\u2019s disease and ankylosing spondylitis. Rheumatology 40, 15\u201323 (2001).","journal-title":"Rheumatology"},{"key":"1331_CR91","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/ard.51.12.1296","volume":"51","author":"S O\u2019Mahony","year":"1992","unstructured":"O\u2019Mahony, S., Anderson, N., Nuki, G. & Ferguson, A. Systemic and mucosal antibodies to Klebsiellain patients with ankylosing spondylitis and Crohn\u2019s disease. Ann. Rheum. Dis. 51, 1296\u20131300 (1992).","journal-title":"Ann. Rheum. Dis."},{"key":"1331_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/PL00006845","volume":"17","author":"H Tiwana","year":"1997","unstructured":"Tiwana, H. et al. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn\u2019s disease and ulcerative colitis. Rheumatol. Int. 17, 11\u201316 (1997).","journal-title":"Rheumatol. Int."},{"key":"1331_CR93","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-2249.1991.tb02944.x","volume":"86","author":"R Lahesmaa","year":"2008","unstructured":"Lahesmaa, R. et al. Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA \u03b11-helix. Clin. Exp. Immunol. 86, 399\u2013404 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"1331_CR94","doi-asserted-by":"publisher","first-page":"32313","DOI":"10.1074\/jbc.M304709200","volume":"278","author":"M Rasmussen","year":"2003","unstructured":"Rasmussen, M., Jacobsson, M. & Bj\u00f6rck, L. Genome-based identification and analysis of collagen-related structural motifs in bacterial and viral proteins. J. Biol. Chem. 278, 32313\u201332316 (2003).","journal-title":"J. Biol. Chem."},{"key":"1331_CR95","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF03342648","volume":"15","author":"A Ebringer","year":"1996","unstructured":"Ebringer, A. et al. Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin. Rheumatol. 15, 57\u201361 (1996).","journal-title":"Clin. Rheumatol."},{"key":"1331_CR96","first-page":"972","volume":"30","author":"C Wilson","year":"2003","unstructured":"Wilson, C. et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J. Rheumatol. 30, 972\u2013978 (2003).","journal-title":"J. Rheumatol."},{"key":"1331_CR97","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","volume":"115","author":"M Pimentel","year":"2020","unstructured":"Pimentel, M., Saad, R. J., Long, M. D. & Rao, S. S. C. ACG clinical guideline: small intestinal bacterial overgrowth. Am. J. Gastroenterol. 115, 165\u2013178 (2020).","journal-title":"Am. J. Gastroenterol."},{"key":"1331_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234906","volume":"15","author":"G Leite","year":"2020","unstructured":"Leite, G. et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. PLoS ONE 15, e0234906 (2020).","journal-title":"PLoS ONE"},{"key":"1331_CR99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cgh.2023.06.001","volume":"22","author":"G Leite","year":"2024","unstructured":"Leite, G. et al. Defining small intestinal bacterial overgrowth by culture and high throughput sequencing. Clin. Gastroenterol. Hepatol. 22, 259\u2013270 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1331_CR100","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/microorganisms10050960","volume":"10","author":"E Rizos","year":"2022","unstructured":"Rizos, E., Pyleris, E., Pimentel, M., Triantafyllou, K. & Giamarellos-Bourboulis, E. J. Small intestinal bacterial overgrowth creates an indigenous proinflammatory environment in the duodenum: a prospective study. Microorganisms 10, 960 (2022).","journal-title":"Microorganisms"},{"key":"1331_CR101","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber, A. D. et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 160, 99\u2013114.e3 (2021).","journal-title":"Gastroenterology"},{"key":"1331_CR102","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy, B. E. et al. Bowel Disorders. Gastroenterology 150, 1393\u20131407.e5 (2016).","journal-title":"Gastroenterology"},{"key":"1331_CR103","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.21037\/atm-21-2779","volume":"9","author":"H-Y Tang","year":"2021","unstructured":"Tang, H.-Y. et al. Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review. Ann. Transl. Med. 9, 1187 (2021).","journal-title":"Ann. Transl. Med."},{"key":"1331_CR104","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.gtc.2024.12.003","volume":"54","author":"EMM Quigley","year":"2025","unstructured":"Quigley, E. M. M. Microbial influences on irritable bowel syndrome. Gastroenterol. Clin. N. Am. 54, 351\u2013365 (2025).","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"1331_CR105","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/gutjnl-2023-331835","volume":"73","author":"S Porcari","year":"2024","unstructured":"Porcari, S. et al. Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73, 1431\u20131440 (2024).","journal-title":"Gut"},{"key":"1331_CR106","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6397","volume":"9","author":"G De Palma","year":"2017","unstructured":"De Palma, G. et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci. Transl. Med. 9, eaaf6397 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1331_CR107","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/nu17030544","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang, H. & Su, Q. Low-FODMAP diet for irritable bowel syndrome: insights from microbiome. Nutrients 17, 544 (2025).","journal-title":"Nutrients"},{"key":"1331_CR108","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12876-021-01693-w","volume":"21","author":"L Mei","year":"2021","unstructured":"Mei, L. et al. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 21, 105 (2021).","journal-title":"BMC Gastroenterol."},{"key":"1331_CR109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","volume":"157","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon, R. et al. Gut microbiota in patients with irritable bowel syndrome-a systematic review. Gastroenterology 157, 97\u2013108 (2019).","journal-title":"Gastroenterology"},{"key":"1331_CR110","doi-asserted-by":"publisher","first-page":"lxae118","DOI":"10.1093\/jambio\/lxae118","volume":"135","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives. J. Appl. Microbiol. 135, lxae118 (2024).","journal-title":"J. Appl. Microbiol."},{"key":"1331_CR111","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj1895","volume":"14","author":"G De Palma","year":"2022","unstructured":"De Palma, G. et al. Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. Sci. Transl. Med. 14, eabj1895 (2022). This study demonstrates the microbial pathway of histamine production and its association with abdominal pain.","journal-title":"Sci. Transl. Med."},{"key":"1331_CR112","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara, G. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693\u2013702 (2004).","journal-title":"Gastroenterology"},{"key":"1331_CR113","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1753425918769372","volume":"24","author":"S Cao","year":"2018","unstructured":"Cao, S. et al. LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets. Innate Immun. 24, 221\u2013230 (2018).","journal-title":"Innate Immun."},{"key":"1331_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02149-4","volume":"23","author":"R Luo","year":"2025","unstructured":"Luo, R., Yao, Y., Chen, Z. & Sun, X. An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein\u2013protein interactions. Cell Commun. Signal. 23, 142 (2025).","journal-title":"Cell Commun. Signal."},{"key":"1331_CR115","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","volume":"31","author":"G Piccinno","year":"2025","unstructured":"Piccinno, G. et al. Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer. Nat. Med. 31, 2416\u20132429 (2025).","journal-title":"Nat. Med."},{"key":"1331_CR116","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","volume":"26","author":"PJ Dziuba\u0144ska-Kusibab","year":"2020","unstructured":"Dziuba\u0144ska-Kusibab, P. J. et al. Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat. Med. 26, 1063\u20131069 (2020).","journal-title":"Nat. Med."},{"key":"1331_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7785","volume":"363","author":"MR Wilson","year":"2019","unstructured":"Wilson, M. R. et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science 363, eaar7785 (2019).","journal-title":"Science"},{"key":"1331_CR118","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"J-P Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de, J.-P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848\u2013851 (2006).","journal-title":"Science"},{"key":"1331_CR119","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/microorganisms11020443","volume":"11","author":"CP Kaur","year":"2023","unstructured":"Kaur, C. P. et al. Presence of polyketide synthase (PKS) gene and counterpart virulence determinants in Klebsiella pneumoniae strains enhances colorectal cancer progression in-vitro. Microorganisms 11, 443 (2023).","journal-title":"Microorganisms"},{"key":"1331_CR120","doi-asserted-by":"publisher","first-page":"149410","DOI":"10.1016\/j.bbrc.2023.149410","volume":"694","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Klebsiella aerogenes exacerbates colon tumorigenesis in the AOM\/DSS-induced C57BL\/6J mouse. Biochem. Biophys. Res. Commun. 694, 149410 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1331_CR121","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1980348","volume":"13","author":"M-K Chiang","year":"2021","unstructured":"Chiang, M.-K. et al. Two ST11 Klebsiella pneumoniae strains exacerbate colorectal tumorigenesis in a colitis-associated mouse model. Gut Microbes 13, 1980348 (2021).","journal-title":"Gut Microbes"},{"key":"1331_CR122","doi-asserted-by":"publisher","first-page":"112199","DOI":"10.1016\/j.celrep.2023.112199","volume":"42","author":"L P\u00f6ltl","year":"2023","unstructured":"P\u00f6ltl, L. et al. Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations. Cell Rep. 42, 112199 (2023).","journal-title":"Cell Rep."},{"key":"1331_CR123","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/s41564-022-01260-3","volume":"7","author":"S Kienesberger","year":"2022","unstructured":"Kienesberger, S. et al. Enterotoxin tilimycin from gut-resident Klebsiella promotes mutational evolution and antibiotic resistance in mice. Nat. Microbiol. 7, 1834\u20131848 (2022).","journal-title":"Nat. Microbiol."},{"key":"1331_CR124","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/s41564-024-01710-0","volume":"9","author":"L Osbelt","year":"2024","unstructured":"Osbelt, L. et al. Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nat. Microbiol. 9, 1792\u20131811 (2024).","journal-title":"Nat. Microbiol."},{"key":"1331_CR125","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.chom.2021.09.003","volume":"29","author":"L Osbelt","year":"2021","unstructured":"Osbelt, L. et al. Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition. Cell Host Microbe 29, 1663\u20131679.e7 (2021).","journal-title":"Cell Host Microbe"},{"key":"1331_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55800-y","volume":"16","author":"\u00c9DH Alm\u00e1si","year":"2025","unstructured":"Alm\u00e1si, \u00c9D. H. et al. Klebsiella oxytoca facilitates microbiome recovery via antibiotic degradation and restores colonization resistance in a diet-dependent manner. Nat. Commun. 16, 551 (2025).","journal-title":"Nat. Commun."},{"key":"1331_CR127","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj3502","volume":"382","author":"F Spragge","year":"2023","unstructured":"Spragge, F. et al. Microbiome diversity protects against pathogens by nutrient blocking. Science 382, eadj3502 (2023).","journal-title":"Science"},{"key":"1331_CR128","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41586-024-07960-6","volume":"633","author":"M Furuichi","year":"2024","unstructured":"Furuichi, M. et al. Commensal consortia decolonize Enterobacteriaceae via ecological control. Nature 633, 878\u2013886 (2024). This study describes a selected consortium of bacteria that can decolonize K. pneumoniae through competition for nutrients.","journal-title":"Nature"},{"key":"1331_CR129","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","volume":"30","author":"J Yuan","year":"2019","unstructured":"Yuan, J. et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 30, 675\u2013688.e7 (2019).","journal-title":"Cell Metab."},{"key":"1331_CR130","doi-asserted-by":"publisher","first-page":"e01170","DOI":"10.1128\/spectrum.01170-23","volume":"11","author":"Z Fan","year":"2023","unstructured":"Fan, Z. et al. The role of integration host factor in biofilm and virulence of high-alcohol-producing Klebsiella pneumoniae. Microbiol. Spectr. 11, e01170\u201323 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR131","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/jgh.15027","volume":"35","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 35, 2009\u20132019 (2020).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1331_CR132","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41564-025-02225-y","volume":"11","author":"CL Hsu","year":"2026","unstructured":"Hsu, C. L. et al. Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort. Nat. Microbiol. 11, 415\u2013428 (2026).","journal-title":"Nat. Microbiol."},{"key":"1331_CR133","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","volume":"70","author":"JDD Pitout","year":"2010","unstructured":"Pitout, J. D. D. Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70, 313\u2013333 (2010).","journal-title":"Drugs"},{"key":"1331_CR134","doi-asserted-by":"publisher","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","volume":"79","author":"PD Tamma","year":"2024","unstructured":"Tamma, P. D. et al. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin. Infect. Dis. 79, ciae403 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR135","doi-asserted-by":"publisher","first-page":"e00344","DOI":"10.1128\/spectrum.00344-24","volume":"12","author":"MS Kang","year":"2024","unstructured":"Kang, M. S. et al. Antimicrobial activity of ceftazidime-avibactam against KPC-2-producing Enterobacterales: a cross-combination and dose-escalation titration study with relebactam and vaborbactam. Microbiol. Spectr. 12, e00344\u201324 (2024).","journal-title":"Microbiol. Spectr."},{"key":"1331_CR136","doi-asserted-by":"publisher","first-page":"9574","DOI":"10.3390\/ijms25179574","volume":"25","author":"A Bucataru","year":"2024","unstructured":"Bucataru, A. et al. Systematic review and meta-analysis of clinical efficacy and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections. Int. J. Mol. Sci. 25, 9574 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1331_CR137","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/jac\/dkab252","volume":"76","author":"D Shortridge","year":"2021","unstructured":"Shortridge, D., Carvalhaes, C., Deshpande, L. & Castanheira, M. Activity of meropenem\/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014\u201319). J. Antimicrob. Chemother. 76, 2600\u20132605 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"1331_CR138","doi-asserted-by":"publisher","first-page":"e01951","DOI":"10.1128\/AAC.01951-19","volume":"64","author":"M Castanheira","year":"2020","unstructured":"Castanheira, M., Doyle, T. B., Kantro, V., Mendes, R. E. & Shortridge, D. Meropenem-vaborbactam activity against carbapenem-resistant Enterobacterales isolates collected in US hospitals during 2016 to 2018. Antimicrob. Agents Chemother. 64, e01951-19 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR139","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1473-3099(24)00499-7","volume":"25","author":"Y Carmeli","year":"2025","unstructured":"Carmeli, Y. et al. Aztreonam\u2013avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial. Lancet Infect. Dis. 25, 218\u2013230 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"1331_CR140","doi-asserted-by":"publisher","first-page":"107113","DOI":"10.1016\/j.ijantimicag.2024.107113","volume":"63","author":"HS Sader","year":"2024","unstructured":"Sader, H. S., Carvalhaes, C. G., Kimbrough, J. H., Mendes, R. E. & Castanheira, M. Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020\u20132022). Int. J. Antimicrob. Agents 63, 107113 (2024).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1331_CR141","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/cid\/cix821","volume":"66","author":"V Leung","year":"2018","unstructured":"Leung, V., Vincent, C., Edens, T. J., Miller, M. & Manges, A. R. Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent clostridium difficile infection. Clin. Infect. Dis. 66, 456\u2013457 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR142","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/cid\/ciw185","volume":"62","author":"B Millan","year":"2016","unstructured":"Millan, B. et al. Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection. Clin. Infect. Dis. 62, 1479\u20131486 (2016). This study shows that FMT reduces the relative abundance of antibiotic resistance genes of the gut microbiome.","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR143","doi-asserted-by":"publisher","first-page":"e00060","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar, A. et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin. Microbiol. Rev. 37, e00060\u201322 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"1331_CR144","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cmi.2019.04.006","volume":"25","author":"S Saha","year":"2019","unstructured":"Saha, S., Tariq, R., Tosh, P. K., Pardi, D. S. & Khanna, S. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review. Clin. Microbiol. Infect. 25, 958\u2013963 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"1331_CR145","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jinf.2022.04.028","volume":"84","author":"J Macare\u00f1o-Castro","year":"2022","unstructured":"Macare\u00f1o-Castro, J., Solano-Salazar, A., Dong, L. T., Mohiuddin, M. & Espinoza, J. L. Fecal microbiota transplantation for carbapenem-resistant Enterobacteriaceae: a systematic review. J. Infect. 84, 749\u2013759 (2022).","journal-title":"J. Infect."},{"key":"1331_CR146","doi-asserted-by":"publisher","first-page":"106216","DOI":"10.1016\/j.jinf.2024.106216","volume":"89","author":"B Davido","year":"2024","unstructured":"Davido, B. et al. Bacterial diversity and specific taxa are associated with decolonization of carbapenemase-producing enterobacterales after fecal microbiota transplantation. J. Infect. 89, 106216 (2024).","journal-title":"J. Infect."},{"key":"1331_CR147","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S2468-1253(23)00357-6","volume":"9","author":"S Porcari","year":"2024","unstructured":"Porcari, S. et al. Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics. Lancet Gastroenterol. Hepatol. 9, 460\u2013475 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1331_CR148","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jama.2023.4314","volume":"329","author":"T Louie","year":"2023","unstructured":"Louie, T. et al. VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA 329, 1356\u20131366 (2023).","journal-title":"JAMA"},{"key":"1331_CR149","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt, P. et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N. Engl. J. Med. 386, 220\u2013229 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1331_CR150","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/cid\/ciy259","volume":"67","author":"ER Dubberke","year":"2018","unstructured":"Dubberke, E. R. et al. Results from a randomized, placebo-controlled clinical trial of a RBX2660-a microbiota-based drug for the prevention of recurrent clostridium difficile infection. Clin. Infect. Dis. 67, 1198\u20131204 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67015-w","volume":"16","author":"V Cabral","year":"2025","unstructured":"Cabral, V. et al. Klebsiella ARO112 promotes microbiota recovery, pathobiont clearance and prevents inflammation in IBD mice. Nat. Commun. 16, 10911 (2025).","journal-title":"Nat. Commun."},{"key":"1331_CR152","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/cid\/ciz782","volume":"70","author":"M Corbellino","year":"2020","unstructured":"Corbellino, M. et al. Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation. Clin. Infect. Dis. 70, 1998\u20132001 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1331_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27656-z","volume":"13","author":"A Eskenazi","year":"2022","unstructured":"Eskenazi, A. et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat. Commun. 13, 302 (2022).","journal-title":"Nat. Commun."},{"key":"1331_CR154","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00919-24","volume":"69","author":"P Zagaliotis","year":"2025","unstructured":"Zagaliotis, P. et al. Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection. Antimicrob. Agents Chemother. 69, e0091924 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1331_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39028-w","volume":"14","author":"L Gan","year":"2023","unstructured":"Gan, L. et al. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Nat. Commun. 14, 3215 (2023). This study shows that bacteriophages can effectively target HiAlc K. pneumoniae.","journal-title":"Nat. Commun."},{"key":"1331_CR156","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.chom.2024.09.004","volume":"32","author":"E Rotman","year":"2024","unstructured":"Rotman, E. et al. Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae. Cell Host Microbe 32, 1988\u20132003.e8 (2024).","journal-title":"Cell Host Microbe"},{"key":"1331_CR157","unstructured":"World Health Organization. Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and Pseudomonas Aeruginosa in Health Care Facilities (WHO, 2017)."},{"key":"1331_CR158","unstructured":"World Health Organization. Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data (WHO, 2023)."},{"key":"1331_CR159","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","volume":"29","author":"C Tanes","year":"2021","unstructured":"Tanes, C. et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe 29, 394\u2013407.e5 (2021).","journal-title":"Cell Host Microbe"},{"key":"1331_CR160","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174726","volume":"134","author":"AL Hecht","year":"2024","unstructured":"Hecht, A. L. et al. Dietary carbohydrates regulate intestinal colonization and dissemination of Klebsiella pneumoniae. J. Clin. Invest. 134, e174726 (2024).","journal-title":"J. Clin. Invest."},{"key":"1331_CR161","unstructured":"World Health Organization. Guidelines: Saturated Fatty Acid and Trans-Fatty Acid Intake for Adults and Children (WHO, 2018)."},{"key":"1331_CR162","unstructured":"World Health Organization. REPLACE: An Action Package to Eliminate Industrially-Produced Trans-Fatty Acids (WHO, 2018)."},{"key":"1331_CR163","unstructured":"World Health Organization. Guideline: Sugars Intake for Adults and Children (WHO, 2015)."},{"key":"1331_CR164","unstructured":"World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013\u20132020 (WHO, 2013)."},{"key":"1331_CR165","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.cell.2025.04.016","volume":"188","author":"S Porcari","year":"2025","unstructured":"Porcari, S. et al. The microbiome for clinicians. Cell 188, 2836\u20132844 (2025).","journal-title":"Cell"},{"key":"1331_CR166","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.cell.2025.01.038","volume":"188","author":"S Turjeman","year":"2025","unstructured":"Turjeman, S., Rozera, T., Elinav, E., Ianiro, G. & Koren, O. From big data and experimental models to clinical trials: iterative strategies in microbiome research. Cell 188, 1178\u20131197 (2025).","journal-title":"Cell"}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01331-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01331-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01331-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:04:20Z","timestamp":1789041860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01331-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":166,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01331-w","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"3 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.P. has served as a speaker for WellMicro. A.G. reports personal fees for consultancy for Eisai, 3PSolutions, Real Time Meeting, Fondazione Istituto Danone, Sinergie Board MRGE and Sanofi. A.G. also reports personal fees for acting as a speaker for Takeda, AbbVie and Sandoz. Furthermore, A.G. reports personal fees for acting on advisory boards for VSL#3 and Eisai. E.E. is a scientific co-founder of DayTwo and BiomX and is an adviser to Purposebio, Aposense, Zoe and MyGutly. G.I. has received personal fees for acting as a speaker for Biocodex and Illumina and as a consultant and adviser to Ferring Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}